San Antonio, Texas
October 27, 2003
Company Working To Lower Trans-Fats In
Response To New Federal Labeling Guidelines
Monsanto Company announced
today that its researchers are applying conventional breeding
and biotechnology techniques to develop soybeans that will
produce oil containing less trans- and saturated fats.
The announcement follows the
recent establishment of federal guidelines that will require
food manufacturers to disclose the amount of trans-fat on food
labels by 2006.
"Monsanto researchers are
looking at ways to enhance soybeans so that they are healthier
and, in turn, can reduce risks that lead to cardiovascular
disease," said David Stark, Monsanto's Vice President of Global
Industry Partnerships. Stark made the announcement today at the
American Dietetic Association's Annual Meeting in San Antonio.
"It is our hope that these
enhanced soybeans will provide economic and environmental
benefits for growers, and healthier agricultural solutions for
consumers who are concerned about their intake of unhealthy
fats."
Specifically, Monsanto is
applying conventional breeding techniques to produce a soybean
low in linolenic acid. The process of hydrogenation reduces the
amount of linolenic acid in soy oil and creates trans-fatty
acids. This soybean would produce a soy oil that reduces the
need for hydrogenation, and, in turn, could help reduce
trans-fats in many foods and even eliminate trans-fats in some.
This product, which is
currently being tested both in the field and laboratory, should
be available in limited quantities in time to meet the federal
government's 2006 labeling guidelines for trans-fats in food
products.
Monsanto also is applying
conventional breeding techniques to produce a soybean high in
oleic acid. This soybean, which also would be low in linolenic
acid, would produce soy oil high in levels of healthy
monounsaturated fat.
Once commercialized, the
company intends to offer these traits in conjunction with its
popular Roundup Ready technology, which has become the product
of choice for American soybean growers.
Finally, Monsanto will apply
biotechnology to develop a soybean that will enable the
production of a trans- and saturated fat-free soy oil, the first
natural oil that could make the claim of being saturated
fat-free.
"Monsanto is committed to
developing products that benefit growers, and to providing new
products that deliver tangible benefits to consumers, including
enhanced nutrition," Stark said.
Trans-fats, which are produced
through the hydrogenation of soy oil to increase its shelf life
or the solid nature of the fat, have been found to raise total
blood cholesterol levels and levels of LDL cholesterol, or "bad"
cholesterol, and may contribute to the risk of cardiovascular
disease.
Monsanto also is researching
other quality improvement traits focused on delivering benefits
to consumers. For example, the company is researching an oilseed
crop that could produce a vegetable oil enriched with Omega-3
fatty acids. Omega-3 fatty acids, typically found in fish oil,
have been shown to play a part in keeping cholesterol levels
low, stabilizing irregular heart beat (arrhythmia), and reducing
blood pressure.
"Given the early stage of
development of this research, we are working closely with
academics, food companies, consumer advocates and other
stakeholders to carefully develop our strategy for potential
future products," Stark said.
"Ultimately, it is our hope
that an Omega-3 enriched oil could provide consumers with a new
tool against heart disease."
Monsanto's research on quality
enhancements to soy oil is consistent with the objective of the
United Soybean Board's Better Bean Initiative (BBI), a program
created to enhance soybean oil and meal composition.
Monsanto Company is a
leading global provider of technology-based solutions and
agricultural products that improve farm productivity and food
quality. For more information on Monsanto, see:
www.monsanto.com.
|